Recent News

• 15 October 2026   Press Release

  Global Drug Discovery Experts Gathered in Riga to Discuss Next-Generation ¹⁹F NMR Screening

  During the Enamine Drug Discovery Conference, held in Riga on 20–23 September 2026, conference guests and participants joined researchers from Enamine and the National Institute of Research and Innovation (NIRI) for a roundtable discussion on "¹⁹F NMR Spectroscopy in Biomedical Research." The discussion took place on 21 September in Sigma Hall and focused on faster, more sensitive methods for fragment-based drug discovery.

• 07 October 2026   Press Release

  Enamine and Ewha Partner to Close the Loop Between AI Design and Real-World Chemistry

  Strategic MOU connects AI-driven design with billions of make-on-demand molecules, rapid synthesis and in-house biology, and builds a new scientific bridge between Korea and Ukraine

• 03 August 2026   Press Release

  SyntheticGestalt and Enamine Build the World’s Largest Experimentally Validated AI-driven Chemical Data Ecosystem

  SyntheticGestalt, a pioneering AI technology company focused on molecular innovation, and Enamine, the developer of the most extensive, synthetically accessible, and trusted chemical space, today announced a landmark collaboration to create the world’s largest in vitro validated AI-driven chemical data ecosystem.